Cognitive Effects of Oral p38 Alpha Kinase Inhibitor Neflamapimod in Dementia With Lewy Bodies
Clinical trial NCT04001517 · COMPLETED
Trial details
- NCT number
- NCT04001517
- Sponsor
- EIP Pharma Inc
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-09-30
- Primary completion
- 2020-06-30
- Enrollment
- 91
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.